BMRA.NASDAQBiomerica INC

SCHEDULE 13G: Wasatch Advisors LP Files Schedule 13G, Reports No Beneficial Ownership in Biomerica Inc.

Sentiment:

Beneficial Ownership Report


Wasatch Advisors LP has filed a Schedule 13G with the SEC, indicating that it holds no beneficial ownership in Biomerica Inc. common stock as of December 31, 2024.

Summary

  • Wasatch Advisors LP, an investment adviser, filed a Schedule 13G with the U.S. Securities and Exchange Commission.
  • The filing reports beneficial ownership of Biomerica Inc. common stock (CUSIP 09061H307) as of December 31, 2024.
  • Wasatch Advisors LP reported 0% aggregate beneficial ownership of Biomerica Inc. common stock.
  • The firm holds no sole or shared voting power, and no sole or shared dispositive power over Biomerica Inc. shares.
  • The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The document is a neutral, factual compliance filing reporting 0% beneficial ownership, with no inherent positive or negative implications for the issuer's operations or financial health.

Positives

  • The filing demonstrates Wasatch Advisors LP's compliance with SEC reporting requirements.
  • The report of 0% ownership indicates no immediate large-scale selling pressure from this specific entity.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Biomerica Inc.'s future outlook.

Industry Context

This filing is a routine compliance disclosure by an investment adviser, Wasatch Advisors LP, and does not provide specific insights into broader industry trends or competitive landscape for Biomerica Inc. It merely reports the investment firm's beneficial ownership stake.

Comparison to Industry Standards

  • This document is a standard regulatory filing (Schedule 13G) required for investment advisers reporting beneficial ownership.
  • It does not contain financial or operational results that can be compared to industry benchmarks or specific comparable companies or projects.

Stakeholder Impact

  • Shareholders: Minimal direct impact as the filing reports no significant change in beneficial ownership by Wasatch Advisors LP (0% stake).

Key Dates

DateDescription
12/31/2024Date of event which requires filing of this statement, reporting beneficial ownership.
02/11/2025Date the Schedule 13G filing was signed by Wasatch Advisors LP.

Keywords

Biomerica Inc, Wasatch Advisors LP, Schedule 13G, SEC filing, Beneficial ownership, Common stock, Investment adviser, Compliance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.